← Back to directory

Flora E. van Leeuwen

Researcher Next ID · RN-033812

Researcher · Biochemistry, Genetics and Molecular Biology

The Netherlands Cancer Institute

Amsterdam, Netherlands

Accepting doctoral researchersFunding unknown
Works count
742
Citation count
41,360
H-index
97
i10-index
359

Research interests

Biochemistry, Genetics and Molecular Biology
Medicine
Breast Cancer Treatment Studies
BRCA gene mutations in cancer
Lymphoma Diagnosis and Treatment
Cancer Risks and Factors
Childhood Cancer Survivors' Quality of Life

Publications

  • Risks of Breast, Ovarian, and Contralateral Breast Cancer for BRCA1 and BRCA2 Mutation Carriers

    JAMA · 2017 · https://doi.org/10.1001/jama.2017.7112

  • European Code against Cancer 4th Edition: 12 ways to reduce your cancer risk

    Cancer Epidemiology · 2015 · https://doi.org/10.1016/j.canep.2015.05.009

  • Radiation Dose-Response Relationship for Risk of Coronary Heart Disease in Survivors of Hodgkin Lymphoma

    Journal of Clinical Oncology · 2015 · 10.1200/jco.2015.63.4444

  • Cardiovascular Disease After Hodgkin Lymphoma Treatment

    JAMA Internal Medicine · 2015 · 10.1001/jamainternmed.2015.1180

  • Second Cancer Risk Up to 40 Years after Treatment for Hodgkin’s Lymphoma

    New England Journal of Medicine · 2015 · 10.1056/nejmoa1505949

  • Genome-Wide Association Study in BRCA1 Mutation Carriers Identifies Novel Loci Associated with Breast and Ovarian Cancer Risk

    PLoS Genetics · 2013 · https://doi.org/10.1371/journal.pgen.1003212

  • Health Council of the Netherlands: No need to change from SAR to time-temperature relation in electromagnetic fields exposure limits

    International Journal of Hyperthermia · 2011 · https://doi.org/10.3109/02656736.2010.534528

  • Subtyping of Breast Cancer by Immunohistochemistry to Investigate a Relationship between Subtype and Short and Long Term Survival: A Collaborative Analysis of Data for 10,159 Cases from 12 Studies

    PLoS Medicine · 2010 · https://doi.org/10.1371/journal.pmed.1000279

  • Associations of Breast Cancer Risk Factors With Tumor Subtypes: A Pooled Analysis From the Breast Cancer Association Consortium Studies

    JNCI Journal of the National Cancer Institute · 2010 · https://doi.org/10.1093/jnci/djq526

  • Cardiometabolic Differences in Children Born After in Vitro Fertilization: Follow-Up Study

    The Journal of Clinical Endocrinology & Metabolism · 2008 · 10.1210/jc.2007-2432

  • Long-Term Risk of Cardiovascular Disease in 10-Year Survivors of Breast Cancer

    JNCI Journal of the National Cancer Institute · 2007 · https://doi.org/10.1093/jnci/djk064

  • Treatment-Specific Risks of Second Malignancies and Cardiovascular Disease in 5-Year Survivors of Testicular Cancer

    Journal of Clinical Oncology · 2007 · 10.1200/jco.2006.10.5296

  • Medical Assessment of Adverse Health Outcomes in Long-term Survivors of Childhood Cancer

    JAMA · 2007 · https://doi.org/10.1001/jama.297.24.2705

  • Physical Activity and Breast Cancer

    Epidemiology · 2006 · 10.1097/01.ede.0000251167.75581.98

  • Late cardiotoxicity after treatment for Hodgkin lymphoma

    Blood · 2006 · https://doi.org/10.1182/blood-2006-07-034405

  • Cumulative Absolute Breast Cancer Risk for Young Women Treated for Hodgkin Lymphoma

    JNCI Journal of the National Cancer Institute · 2005 · 10.1093/jnci/dji290

  • Long-Term Cause-Specific Mortality of Patients Treated for Hodgkin’s Disease

    Journal of Clinical Oncology · 2003 · 10.1200/jco.2003.07.131

  • Breast Cancer Following Radiotherapy and Chemotherapy Among Young Women With Hodgkin Disease

    JAMA · 2003 · 10.1001/jama.290.4.465

  • Roles of Radiation Dose, Chemotherapy, and Hormonal Factors in Breast Cancer Following Hodgkin's Disease

    JNCI Journal of the National Cancer Institute · 2003 · 10.1093/jnci/95.13.971

  • Second Malignant Neoplasms Among Long-Term Survivors of Hodgkin’s Disease: A Population-Based Evaluation Over 25 Years

    Journal of Clinical Oncology · 2002 · 10.1200/jco.2002.09.038

  • Long-Term Risk of Second Malignancy in Survivors of Hodgkin’s Disease Treated During Adolescence or Young Adulthood

    Journal of Clinical Oncology · 2000 · 10.1200/jco.2000.18.3.487

  • Risk and prognosis of endometrial cancer after tamoxifen for breast cancer

    The Lancet · 2000 · 10.1016/s0140-6736(00)02677-5

  • Risk of Second Malignant Neoplasms Among Long-term Survivors of Testicular Cancer

    JNCI Journal of the National Cancer Institute · 1997 · 10.1093/jnci/89.19.1429

  • Risk of endometrial cancer after tamoxifen treatment of breast cancer

    The Lancet · 1994 · 10.1016/s0140-6736(94)92692-1

  • Second cancer risk following Hodgkin's disease: a 20-year follow-up study.

    Journal of Clinical Oncology · 1994 · 10.1200/jco.1994.12.2.312

  • Leukemia Following Hodgkin's Disease

    New England Journal of Medicine · 1990 · https://doi.org/10.1056/nejm199001043220102

Current projects

    No projects listed.